BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 8713155)

  • 1. Making tough decisions.
    Vail S
    Can Nurse; 1995 Dec; 91(11):60, 59. PubMed ID: 8713155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decision makers' views on health care objectives and budget constraints: results from a pilot study.
    Al MJ; Feenstra T; Brouwer WB
    Health Policy; 2004 Oct; 70(1):33-48. PubMed ID: 15312708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluation in critical care medicine.
    Cox HL; Laupland KB; Manns BJ
    J Crit Care; 2006 Jun; 21(2):117-24. PubMed ID: 16769454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
    Adang E; Voordijk L; Jan van der Wilt G; Ament A
    Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difficult decisions: weighing treatment costs and benefits.
    Wainio JA
    Hosp Technol Ser; 1995 Jan; 14(1):1-3. PubMed ID: 10140805
    [No Abstract]   [Full Text] [Related]  

  • 6. Thinking about equity in health care.
    Williams A
    J Nurs Manag; 2005 Sep; 13(5):397-402. PubMed ID: 16108777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reimbursement and clinical guidance for pharmaceuticals in Sweden: do health-economic evaluations support decision making?
    Anell A; Persson U
    Eur J Health Econ; 2005 Sep; 6(3):274-9. PubMed ID: 15968561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis and formulary decision making in England: findings from research.
    Williams IP; Bryan S
    Soc Sci Med; 2007 Nov; 65(10):2116-29. PubMed ID: 17698271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of cost-effectiveness analysis to multiple products: a practical guide.
    Bala MV; Zarkin GA
    Am J Manag Care; 2002 Mar; 8(3):211-8. PubMed ID: 11915971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The production economics of nursing: a discussion paper.
    Newbold D
    Int J Nurs Stud; 2008 Jan; 45(1):120-8. PubMed ID: 17379228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of cost-effectiveness by the National Institute for Health and Clinical Excellence (NICE): no(t yet an) exemplar of a deliberative process.
    Schlander M
    J Med Ethics; 2008 Jul; 34(7):534-9. PubMed ID: 18591289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical resource allocation: rationing and ethical considerations--Part I.
    Elfenbein P; Miller JB; Milakovich M
    Physician Exec; 1994 Feb; 20(2):3-8. PubMed ID: 10132135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prioritizing investments in health: can we assess potential value for money?
    Drummond M
    J Rheumatol Suppl; 2003 Dec; 68():19-20. PubMed ID: 14712616
    [No Abstract]   [Full Text] [Related]  

  • 14. Can our health services be saved by technology evaluation? The Quebec experience.
    McGregor M
    Clin Invest Med; 1994 Aug; 17(4):334-42. PubMed ID: 7982297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hard choices in public health: the allocation of scarce resources.
    Liss PE
    Scand J Public Health; 2003; 31(2):156-7. PubMed ID: 12745767
    [No Abstract]   [Full Text] [Related]  

  • 16. [Who shall live? Economic and political implications of rationing in health care].
    Köck CM
    Osterr Krankenpflegez; 1998; 51(6-7):4. PubMed ID: 9709100
    [No Abstract]   [Full Text] [Related]  

  • 17. Empiricism, ethics and orthodox economic theory: what is the appropriate basis for decision-making in the health sector?
    Richardson J; McKie J
    Soc Sci Med; 2005 Jan; 60(2):265-75. PubMed ID: 15522484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resource allocation and the beginning of life.
    Bennett B
    J Contemp Health Law Policy; 1993; 9():77-90. PubMed ID: 10126949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmaco-economic evaluations of new drugs: potential key to a more efficient allocation of the health care budget].
    Delwel GO; Sprenger MJ
    Ned Tijdschr Geneeskd; 2002 Jun; 146(23):1068-71. PubMed ID: 12085554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using cost-effectiveness/cost-benefit analysis to allocate health resources: a level playing field for prevention?
    Phillips KA; Hotlgrave DR
    Am J Prev Med; 1997; 13(1):18-25. PubMed ID: 9037338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.